Vaxelis™ DTaP, Polio, Hib, and Hepatitis B Vaccine Indicated for People 6 Weeks Through 4 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine Injection Single-Dose Vial 0.5 mL

Name: Vaxelis™ DTaP, Polio, Hib, and Hepatitis B Vaccine Indicated for People 6 Weeks Through 4 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine Injection Single-Dose Vial 0.5 mL
Brand: Vaxelis™
SKU: USAMP#17671663
Price: 2089.4 USD
Availability: InStock

USAMP#17671663SKU: 63361024310Vaxelis™

License Required

Product Spotlight

VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit

Product Spotlight

VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit